Encapsulated papillary carcinoma of the breast (EPC) is a rare type of papillary neoplasm. It accounts for 0.5-1% of all breast cancers. 1 Described as a well-circumscribed malignant papillary mass surrounded by thick fibrous capsule, EPCs typically presents in postmenopausal woman (between 55 to 67 years of age). 2,3 It is generally considered as a low risk cancer, with a 5% local recurrence risk and an overall favourable prognosis. 4 Although it is debatable if EPCs should be treated as an in-situ or invasive carcinoma, 4 EPCs are often managed as an in-situ disease because of its indolent clinical behaviour. EPCs uniquely express a pattern of invasion-associated markers between DCIS and invasive breast cancer (IBC). On one hand, EPC is notoriously difficult to diagnose pre-operatively with